Glutamatergic agents for the treatment of cognitive impairments in patients with schizophrenia

被引：0
|
作者：
Buchanan, RW [1 ]
Gold, JM [1 ]
Bilder, R [1 ]
Green, M [1 ]
Javitt, DC [1 ]
Marder, SR [1 ]
Schooler, NR [1 ]
Heresco-Levy, U [1 ]
McMahon, RP [1 ]
Carpenter, WT [1 ]
机构：
[1] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA
来源：
SCHIZOPHRENIA BULLETIN | 2005年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [1] Glutamatergic agents for the treatment of negative symptoms and cognitive impairments in patients with schizophrenia
    Buchanan, RW
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 5S - 5S
  • [2] The Cognitive and Negative Symptoms in Schizophrenia, Trial (CONSIST): The efficacy of glutamatergic agents for negative symptoms and cognitive impairments
    Buchanan, Robert W.
    Javitt, Daniel C.
    Marder, Stephen R.
    Schooler, Nina R.
    Gold, James M.
    McMahon, Robert P.
    Heresco-Levy, Uriel
    Carpenter, William T.
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (10): : 1593 - 1602
  • [3] Glutamatergic agents for the treatment of schizophrenia
    Buchanan, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S134 - S135
  • [4] Galantamine for the treatment of cognitive impairments in patients with schizophrenia
    Buchanan, Robert W.
    Conley, Robert C.
    Dickinson, Dwight
    Nelson, Matthew W.
    Gold, James M.
    Mcmahon, Robert P.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S245 - S245
  • [5] Galantamine for the treatment of cognitive impairments in patients with schizophrenia
    Buchanan, R. W.
    Conley, R. C.
    Dickinson, D.
    Nelson, M. W.
    Gold, J. M.
    McMahon, R. P.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 424 - 424
  • [6] Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia
    Buchanan, Robert W.
    Freedman, Robert
    Javitt, Daniel C.
    Abi-Dargham, Anissa
    Lieberman, Jeffrey A.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (05) : 1120 - 1130
  • [7] Glutamatergic agents for schizophrenia
    不详
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2007, 11 (09) : 42 - 43
  • [8] Prenatal Infection Links GABAergic and Glutamatergic Dysfunctions to Cognitive Impairments Relevant to Schizophrenia
    Meyer, Urs
    BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 198S - 199S
  • [9] Galantamine for the treatment of cognitive impairments in people with schizophrenia
    Buchanan, Robert W.
    Conley, Robert R.
    Dickinson, Dwight
    Ball, M. Patricia
    Feldman, Stephanie
    Gold, James M.
    McMahon, Robert P.
    AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (01): : 82 - 89
  • [10] CHILDHOOD TRAUMA AND COGNITIVE IMPAIRMENTS IN PATIENTS WITH SCHIZOPHRENIA
    Won, Seunghee
    Kim, Do Hoon
    Kim, Jiwoo
    Koo, Taehoon
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S126 - S126
12345